[Diarrhea predominant irritable bowel syndrome]
Related Experiment Video
Updated: Jul 3, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Jean-Marc Sabaté1, Benoît Coffin
1Service d'hepato-gastroentŕologie, Hôpital Louis-Mourier, AP-HP 92700 Colombes, France.
Abstract:
The diagnosis of diarrhea predominant irritable bowel syndrome (D-IBS) should be a positive diagnosis, based on Rome criteria, and not a diagnosis of exclusion. However, it is in this situation that investigations are frequently performed. But full and complete explorations are not systematically required as they are frequently normal, and normal results do not have a positive influence on symptom evolution. Treatment of D-IBOS is mainly based on antispasmodics and antidiarrheal agents antidepressant agent can be used.
Related Concept Videos
Irritable Bowel Syndrome
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction

